Skip to content

BIOSYNERGY INC: 10-Q filed 2021-12-15

What BIOSYNERGY INC reported in its quarterly report filed 2021-12-15 (fiscal Q2 2022): 30 published measures, 80 facts as tagged in accession 0001437749-21-028652.

This filing

Form
10-Q (quarterly report)
Filed
2021-12-15
Fiscal period
fiscal Q2 2022
Accession
0001437749-21-028652 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All BIOSYNERGY INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-10-311,819,755USD
At 2021-04-301,891,514USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-10-311,673,116USD
At 2021-04-301,738,996USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-08-01 to 2021-10-3123,682USD92
2021-05-01 to 2021-10-31-65,880USD184
2020-08-01 to 2020-10-3128,142USD92
2020-05-01 to 2020-10-3114,923USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-05-01 to 2021-10-31-162,797USD184
2020-05-01 to 2020-10-3114,859USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-10-311,036,990USD
At 2021-04-301,102,870USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-08-01 to 2021-10-319,060USD92
2021-05-01 to 2021-10-31-26,261USD184
2020-08-01 to 2020-10-3111,217USD92
2020-05-01 to 2020-10-315,948USD184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-10-31831USD
At 2021-04-303,063USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-08-01 to 2021-10-3132,398USD92
2021-05-01 to 2021-10-31-93,297USD184
2020-08-01 to 2020-10-3138,764USD92
2020-05-01 to 2020-10-3119,654USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-10-311,677,703USD
At 2021-04-301,694,529USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-10-31146,639USD
At 2021-04-30127,526USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-10-3192,959USD
At 2021-04-303,189USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2021-10-31426,190USD
At 2021-04-30264,509USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-08-01 to 2021-10-31217,674USD92
2021-05-01 to 2021-10-31413,136USD184
2020-08-01 to 2020-10-31164,809USD92
2020-05-01 to 2020-10-31363,487USD184

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-10-31132,390USD
At 2021-04-30145,178USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-08-01 to 2021-10-31250,072USD92
2021-05-01 to 2021-10-31319,839USD184
2020-08-01 to 2020-10-31203,573USD92
2020-05-01 to 2020-10-31383,141USD184

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2021-08-01 to 2021-10-31271,949USD92
2021-05-01 to 2021-10-31377,020USD184
2020-08-01 to 2020-10-31109,935USD92
2020-05-01 to 2020-10-31221,818USD184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-08-01 to 2021-10-3129,911USD92
2021-05-01 to 2021-10-3159,310USD184
2020-08-01 to 2020-10-3136,787USD92
2020-05-01 to 2020-10-3176,840USD184

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-10-3148,285USD
At 2021-04-3096,570USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2021-10-31202,621USD
At 2021-04-30202,621USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2021-10-31201,790USD
At 2021-04-30199,558USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2021-10-310USD
At 2021-04-3024,992USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-08-01 to 2021-10-3132,742USD92
2021-05-01 to 2021-10-31-92,141USD184
2020-08-01 to 2020-10-3139,359USD92
2020-05-01 to 2020-10-3120,871USD184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-08-01 to 2021-10-31165,170USD92
2021-05-01 to 2021-10-31297,068USD184
2020-08-01 to 2020-10-3188,953USD92
2020-05-01 to 2020-10-31202,492USD184

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-05-01 to 2021-10-312,232USD184
2020-05-01 to 2020-10-312,232USD184

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2021-05-01 to 2021-10-315,685USD184
2020-05-01 to 2020-10-316,822USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-08-01 to 2021-10-31344USD92
2021-05-01 to 2021-10-311,156USD184
2020-08-01 to 2020-10-31595USD92
2020-05-01 to 2020-10-311,217USD184

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2021-05-01 to 2021-10-31-26,261USD184
2020-05-01 to 2020-10-310USD184

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-05-01 to 2021-10-310USD184
2020-05-01 to 2020-10-310USD184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-05-01 to 2021-10-31161,681USD184
2020-05-01 to 2020-10-31-805USD184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-05-01 to 2021-10-31-12,788USD184
2020-05-01 to 2020-10-31-11,168USD184

Inspect the source

Entity
BIOSYNERGY INC / CIK 0000715812
Captured
SEC response SHA-256
eb912604535d1396c8e2ed6025c6adab35af75fdfc7239083d444e5a31df6a03

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000715812.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))